These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 29755657)

  • 1. Regulatory effect of anti-gp130 functional mAb on IL-6 mediated RANKL and Wnt5a expression through JAK-STAT3 signaling pathway in FLS.
    Miao P; Zhou XW; Wang P; Zhao R; Chen N; Hu CY; Chen XH; Qian L; Yu QW; Zhang JY; Xu R; He DY; Xiao LB; Li P; Lu M; Zhang DQ
    Oncotarget; 2018 Apr; 9(29):20366-20376. PubMed ID: 29755657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An herbal formula inhibits STAT3 signaling and attenuates bone erosion in collagen-induced arthritis rats.
    Chen YJ; Wu JY; Leung WC; Liu YX; Fu XQ; Zhu JQ; Wu Y; Chou JY; Yin CL; Wang YP; Wang XQ; Bai JX; Wu ZZ; Yu ZL
    Phytomedicine; 2020 May; 76():153254. PubMed ID: 32531698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways.
    Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY
    Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory effect of calcineurin inhibitor, tacrolimus, on IL-6/sIL-6R-mediated RANKL expression through JAK2-STAT3-SOCS3 signaling pathway in fibroblast-like synoviocytes.
    Choe JY; Park KY; Park SH; Lee SI; Kim SK
    Arthritis Res Ther; 2013 Feb; 15(1):R26. PubMed ID: 23406906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway.
    Niu HQ; Zhao WP; Zhao XC; Luo J; Qin KL; Chen KL; Li XF
    Int Immunopharmacol; 2018 Aug; 61():45-53. PubMed ID: 29803913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-apoptotic effect of interleukin-22 on fibroblast-like synoviocytes in patients with rheumatoid arthritis is mediated via the signal transducer and activator of transcription 3 signaling pathway.
    Zhao M; Li Y; Xiao W
    Int J Rheum Dis; 2017 Feb; 20(2):214-224. PubMed ID: 27493089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL16 upregulates RANKL expression in rheumatoid arthritis synovial fibroblasts through the JAK2/STAT3 and p38/MAPK signaling pathway.
    Li CH; Xu LL; Zhao JX; Sun L; Yao ZQ; Deng XL; Liu R; Yang L; Xing R; Liu XY
    Inflamm Res; 2016 Mar; 65(3):193-202. PubMed ID: 26621504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sFRP3 and DKK1 Regulate Fibroblast-Like Synoviocytes Markers and Wnt Elements Expression Depending on Cellular Context.
    Elhaj Mahmoud D; Sassi N; Drissi G; Barsaoui M; Zitouna K; Sahli H; Kallel-Sellami M; Kanoun L; Cheour E; Laadhar L
    Immunol Invest; 2017 Apr; 46(3):314-328. PubMed ID: 28151034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-33 acts as a transcriptional repressor and extracellular cytokine in fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Lee EJ; So MW; Hong S; Kim YG; Yoo B; Lee CK
    Cytokine; 2016 Jan; 77():35-43. PubMed ID: 26520876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR-3 enhances osteoclastogenesis through upregulation of RANKL expression from fibroblast-like synoviocytes in patients with rheumatoid arthritis.
    Kim KW; Cho ML; Oh HJ; Kim HR; Kang CM; Heo YM; Lee SH; Kim HY
    Immunol Lett; 2009 May; 124(1):9-17. PubMed ID: 19446344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chrysoeriol suppresses hyperproliferation of rheumatoid arthritis fibroblast-like synoviocytes and inhibits JAK2/STAT3 signaling.
    Wu JY; Chen YJ; Fu XQ; Li JK; Chou JY; Yin CL; Bai JX; Wu Y; Wang XQ; Li AS; Wong LY; Yu ZL
    BMC Complement Med Ther; 2022 Mar; 22(1):73. PubMed ID: 35296317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased sensitivity of rheumatoid synoviocytes to Schnurri-3 expression in TNF-α and IL-17A induced osteoblastic differentiation.
    Lavocat F; Osta B; Miossec P
    Bone; 2016 Jun; 87():89-96. PubMed ID: 27072520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation.
    Kim KW; Cho ML; Lee SH; Oh HJ; Kang CM; Ju JH; Min SY; Cho YG; Park SH; Kim HY
    Immunol Lett; 2007 May; 110(1):54-64. PubMed ID: 17467812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cytokines regulate osteoclastogenesis in rheumatoid arthritis.
    Kim KW; Kim HR; Kim BM; Cho ML; Lee SH
    Am J Pathol; 2015 Nov; 185(11):3011-24. PubMed ID: 26362732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exogenous IFN-beta regulates the RANKL-c-Fos-IFN-beta signaling pathway in the collagen antibody-induced arthritis model.
    Zhao R; Chen NN; Zhou XW; Miao P; Hu CY; Qian L; Yu QW; Zhang JY; Nie H; Chen XH; Li P; Xu R; Xiao LB; Zhang X; Liu JR; Zhang DQ
    J Transl Med; 2014 Dec; 12():330. PubMed ID: 25491303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid arthritis fibroblast-like synoviocytes express BCMA and are stimulated by APRIL.
    Nagatani K; Itoh K; Nakajima K; Kuroki H; Katsuragawa Y; Mochizuki M; Aotsuka S; Mimori A
    Arthritis Rheum; 2007 Nov; 56(11):3554-63. PubMed ID: 17968879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Effects of IL-17A and TNF-α on Osteoblastic Differentiation of Isolated Synoviocytes and on Bone Explants from Arthritis Patients.
    Osta B; Roux JP; Lavocat F; Pierre M; Ndongo-Thiam N; Boivin G; Miossec P
    Front Immunol; 2015; 6():151. PubMed ID: 25904914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 upregulates expression of ADAMTS-4 in fibroblast-like synoviocytes from patients with rheumatoid arthritis.
    Mimata Y; Kamataki A; Oikawa S; Murakami K; Uzuki M; Shimamura T; Sawai T
    Int J Rheum Dis; 2012 Feb; 15(1):36-44. PubMed ID: 22324945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
    Lee CK; Lee EY; Chung SM; Mun SH; Yoo B; Moon HB
    Arthritis Rheum; 2004 Dec; 50(12):3831-43. PubMed ID: 15593184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts.
    Kim KW; Kim HR; Park JY; Park JS; Oh HJ; Woo YJ; Park MK; Cho ML; Lee SH
    Arthritis Rheum; 2012 Apr; 64(4):1015-23. PubMed ID: 22034096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.